EMulate Therapeutics’ Chris E. Rivera and Xavier A. Figueroa, Ph.D., discuss how the information about a therapeutic molecule can be captured as a digital signature or “song,” the company’s disruptive technology through which playing the "song" can emulate the therapeutic effects of the molecule, and how it may help usher in a true digital transformation in healthcare.
.svg)
